Your session is about to expire
← Back to Search
Brachial artery ultrasound imaging for Cardiovascular Disease
N/A
Waitlist Available
Research Sponsored by Everist Genomics, Inc
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 day
Awards & highlights
Summary
The objective of the study is to define the analytical repeatability of quantifying flow-mediated dilation of the brachial artery using brachial artery ultrasound imaging using upper arm cuff occlusion.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 day
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 day
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change from baseline % flow-mediated dilation (%FMD) at 1 hour
Secondary outcome measures
Incidence of emergent adverse device effects (ADEs) according to CTCAE v4.03
Trial Design
1Treatment groups
Experimental Treatment
Group I: Brachial artery ultrasound imagingExperimental Treatment1 Intervention
Brachial artery ultrasound imaging is a non-invasive procedure for detecting endothelial dysfunction by measuring the flow-mediated dilation of the brachial artery using high resolution continuous electrocardiogram-gated B-mode (2D) ultrasound imaging during reactive hyperemia.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Brachial artery ultrasound imaging
2016
N/A
~30
Find a Location
Who is running the clinical trial?
Everist Genomics, IncLead Sponsor
2 Previous Clinical Trials
191 Total Patients Enrolled
Peter F Lenehan, MD PhDStudy ChairEverist Health
2 Previous Clinical Trials
191 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger